Mr. Davis joined Acadia Pharmaceuticals in July 2014 as Executive Vice President, Chief Financial Officer and Chief Business Officer. He was appointed Interim Chief Executive Officer in March 2015 and named President and Chief Executive Officer in September 2015.

Mr. Davis brings over 25 years of executive-level experience in the pharmaceutical industry and more than 25 years of experience on the boards of directors of publicly held biopharmaceutical companies. Previously, Mr. Davis served as Executive Vice President and Chief Operating Officer at Heron Therapeutics, Inc., Executive Vice President and Chief Operating Officer at Ardea Biosciences, Inc., and in numerous executive roles at Neurogen Corporation, including Chief Executive Officer.

Mr. Davis currently serves on the board of directors of Bellicum Pharmaceuticals, Inc. He also recently served on the boards of directors of Heron Therapeutics Inc., Synageva BioPharma Corp., and Furiex Pharmaceuticals, Inc. Early in his career, Mr. Davis practiced as a Certified Public Accountant with a major accounting firm and as a corporate and securities attorney with a Wall Street law firm. Mr. Davis received his BS degree in Accounting from Southern Nazarene University and a JD from Vanderbilt University.